Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of low intensity allogeneic transplantation in Mantle Cell Lymphoma
2007-003081-18Phase 2Completed
- Sponsor
- University College Hospital
- Start
- May 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cytarabine, carmustine, lomustine, melphalan and etoposide in mantle cell lymphoma (MCL), sponsored by University College Hospital. Primary endpoint: Progression free survival. Started May 2008; status: completed.
02
Drugs
cytarabinecarmustinelomustinemelphalanetoposide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2007-003081-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003081-18.